Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-04-01

Clinical Trial Update: Efficacy and Safety of Insulin Glargine Versus. Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabetes Above 6 Years Old. [Phase 3]

View source ↗

Summary

A Phase 3 trial compared insulin glargine with NPH insulin in children over 6 years old with Type 1 diabetes to assess efficacy and safety. The study has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin Glargine (insulin glargine)
  • Neutral Protamine Hagedorn insulin (insulin NPH)

Snippet

Sponsor: Sanofi | Conditions: Type 1 Diabetes Mellitus | Phase 3 | Status: COMPLETED